in nocturnal BP (Ͼ35 mm Hg, 28% of the 24-hour mean) between extreme-dipper and riser hypertensive patients. Accordingly, the lack of nocturnal decline in BP cannot be justified by changes in physical activity alone.
P-127 TIME-QUALIFIED TOLERANCE LIMITS FOR AMBULATORY BLOOD PRESSURE MONITORING IN THE DIAGNOSIS OF HYPERTENSION
To recognize the highly significant circadian variability of blood pressure (BP) is to admit that the diagnosis of hypertension should be based not just on whether a casual BP value is too high, but rather on more pertinent questions: How long is BP elevated above a given time-varying threshold? What is the excess BP? When most of the excess occurs? Answers to these questions may be obtained by establishing, first, an adequate reference BP threshold and, second, a proper measurement of BP elevation [Hermida et al. Hypertension. 2000; 35:118-125] . Accordingly, we derived time-specified reference standards for BP as a function of gender. We studied 375 normotensive volunteers (200 men), 43.1Ϯ1.0 (meamϮSE) years of age, without medical history of hypertension and diurnal mean of ambulatory monitored BP below 135/85 mm Hg for systolic/diastolic BP. BP was measured at 20-minute intervals during the day (07:00 to 23:00 hours) and at 30-minute intervals at night for 48 consecutive hours with an ambulatory Spacelabs 90207 device. Physical activity was simultaneously monitored by wrist actigraphy. Data from each BP series were synchronized according to the rest-activity cycle of each individual in order to avoid differences among subjects in actual times of daily activity. Data were then used to compute 90% circadian tolerance intervals for each gender separately, in keeping with the gender differences in BP previously documented [Hermida. Blood Pres Monit. 1999; 4:137-147] . The method, derived on the basis of bootstrap techniques, does not need to assume normality or symmetry in the data and, therefore, it is highly appropriate to describe the circadian pattern of BP variability. Results not only reflect expected changes in the tolerance limits as a function of gender and circadian time of sampling, but also upper limits below the thresholds currently used for diagnosing hypertension, specially for women. The use of these circadian time-dependent tolerance limits for the computation of a hyperbaric index as a measure of BP excess has already been shown to provide a reproducible and high-sensitivity test for the diagnosis of hypertension [Hermida et al. Hypertension. 2000; 35:118-125] , that can also be used for evaluating a given patient's response to treatment. Recent studies have tried to overcome poor results from isolated blood pressure (BP) measurements in detecting preeclampsia by relying on ambulatory BP monitoring (ABPM). Poor results from the test based on the 24-hour BP mean [Hermida & Ayala. Hypertension. 1997; 30:1531 -1537 have lead many authors to extrapolate that ABPM is not a valid approach in pregnancy. Against this background, we have evaluated prospectively whether the tolerance-hyperbaric test (THT), combined approach of establishing tolerance intervals for the circadian variability of BP as a function of gestational age, and then computing the hyperbaric index (HBI, area of BP excess above the upper limit of the interval) by comparison of any patient's BP profile with those intervals, provides high sensitivity for the identification of pregnant women who subsequently will develop gestational hypertension or preeclampsia. We analyzed 2430 BP series obtained from 235 women with uncomplicated pregnancies and 168 who developed gestational hypertension or preeclampsia. BP was measured at 20-minute intervals during the day (07:00 to 23:00 hours) and at 30-minute intervals at night for 48 consecutive hours once every 4 weeks from the first obstetric visit (mostly before 14 weeks of gestation) until delivery. Circadian 90% tolerance limits for BP were computed as a function of trimester of pregnancy from 497 BP series previously sampled from an independent reference group of 189 normotensive pregnant women. The HBI was then determined for each BP series in the validation sample. Sensitivity of the THT was 92.7% for women sampled during the first trimester of gestation, and increased up to 99.2% in the third trimester. Specificity was above 99% in all trimes-
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